Peter Alperin
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
-
- Colorectal Cancer Screening and Detection
Papers in
- Co-authors
- David Eddy (2 shared papers)M. Sue Kirkman (1 shared paper)John B. Buse (1 shared paper)Knut Borch‐Johnsen (1 shared paper)Richard Kahn (1 shared paper)Rury R. Holman (1 shared paper)Justin Feigelman (1 shared paper)Michael P. Stern (1 shared paper)
- Journals
- PLoS ONE (3 papers)Journal of Clinical Oncology (1 paper)Diabetes Obesity and Metabolism (1 paper)Clinical Gastroenterology and Hepatology (1 paper)Journal of General Internal Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Peter Alperin
13 papers receiving 495 citations
Peers
Comparison fields: 5 of 66
- Endocrinology, Diabetes and Metabolism 159
- Oncology 70
- Pharmacy 11
- Family Practice 4
- Rheumatology 31
Countries citing papers authored by Peter Alperin
This map shows the geographic impact of Peter Alperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Alperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Alperin more than expected).
Fields of papers citing papers by Peter Alperin
This network shows the impact of papers produced by Peter Alperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Alperin. The network helps show where Peter Alperin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Alperin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 195 | |
| 2 | 2014 | 82 | |
| 3 | 1990 | 69 | |
| 4 | 2013 | 44 | |
| 5 | 2013 | 32 | |
| 6 | 2011 | 21 | |
| 7 | 2012 | 19 | |
| 8 | 2012 | 15 | |
| 9 | 2012 | 14 | |
| 10 | 2014 | 12 | |
| 11 | 2011 | 11 | |
| 12 | 2010 | 6 | |
| 13 | 2011 | 1 | |
| 14 | 2010 | 0 |
About Peter Alperin
Peter Alperin is a scholar working on Surgery, Oncology, Endocrinology, Diabetes and Metabolism, Physiology and Economics and Econometrics, having authored 14 papers that have together received 521 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Asthma and respiratory diseases (2 papers), Colorectal Cancer Screening and Detection (2 papers), Eicosanoids and Hypertension Pharmacology (1 paper), Fatty Acid Research and Health (1 paper), BRCA gene mutations in cancer (1 paper) and Inhalation and Respiratory Drug Delivery (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (159 citations), Oncology (70 citations), Pharmacy (11 citations), Family Practice (4 citations) and Rheumatology (31 citations). Peter Alperin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include David Eddy, M. Sue Kirkman, John B. Buse, Knut Borch‐Johnsen, Richard Kahn, Rury R. Holman, Justin Feigelman, Michael P. Stern, Jaakko Tuomilehto and Edward W. Gregg. Their work appears in journals such as PLoS ONE, Journal of Clinical Oncology, Diabetes Obesity and Metabolism, Clinical Gastroenterology and Hepatology and Journal of General Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.